These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3094944)

  • 1. Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients.
    Satam MN; Suraiya JN; Nadkarni JJ
    Cancer Immunol Immunother; 1986; 23(1):56-9. PubMed ID: 3094944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
    Fukui H; Overton WR; Herberman RB; Reynolds CW
    J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
    Timonen T; Ortaldo JR; Herberman RB
    J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
    Klein M; Roder J; Haliotis T; Korec S; Jett JR; Herberman RB; Katz P; Fauci AS
    J Exp Med; 1980 May; 151(5):1049-58. PubMed ID: 6966316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No alteration in NK function or zeta chain expression in NK and T cells of cervical cancer patients.
    Onon TS; Kitchener HC; Duggan-Keen M; Stern PL
    Gynecol Oncol; 2003 Apr; 89(1):120-8. PubMed ID: 12694665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome.
    Argov S; Johnson DR; Collins M; Koren HS; Lipscomb H; Purtilo DT
    Cell Immunol; 1986 Jun; 100(1):1-9. PubMed ID: 3742598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
    Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
    Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percoll density gradient centrifugation. (An improved method for the enrichment of lymphocyte subsets mediating different activities).
    Fumarola D; Antonaci S; Jirillo E; Munno I; Lucivero G; Bonomo L
    Ric Clin Lab; 1982; 12(3):485-91. PubMed ID: 6291125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.
    Mehta BA; Satam MN; Advani SH; Nadkarni JJ
    Cancer Immunol Immunother; 1989; 28(2):148-52. PubMed ID: 2917365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer lymphocyte function in cervical cancer patients.
    Pulay TA; Benczur M; Varga M
    Neoplasma; 1982; 29(2):237-40. PubMed ID: 7110449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A; Herberman RB; Holden HT
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and antibody-dependent cellular cytotoxicity in tumour-adherent T lymphocytes: expression of Fc receptors and of a human T-subgroup-specific antigen.
    Feucht HE; Hadam MR; Lohmeyer J; Frank F; Reiber EP; Riethmüller G
    Scand J Immunol; 1981 May; 15(5):483-92. PubMed ID: 6179156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome.
    Kerndrup G; Meyer K; Ellegaard J; Hokland P
    Leuk Res; 1984; 8(2):239-47. PubMed ID: 6717064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
    von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside TL
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):202-7. PubMed ID: 9067656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.